A Novel Chimeric Antigen as a Vaccine Candidate against Leishmania major: In silico Analysis

Background: Leishmania is a mandatory intracellular pathogen and causing neglected disease. Hence, protection against leishmaniasis by a development vaccine is an important subject. This study aimed to design a poly-epitope vaccine for cutaneous leishmaniasis. Methods: The present study was conducted in the Parasitology Department of Tarbiat Modares University, Tehran, Iran during 2017–2019. Several bioinformatics methods at online servers were used for prediction of different aspects of poly-epitope, including, physico-chemical attributes, allergenicity, antigenicity, secondary and tertiary structures, B-cell, T-cell and MHC (I, II) potential epitopes of LACK, LEIF, GP63 and SMT antigens of L. major. Results: After designing the construct (GLSL), the outputs of PTM sites demonstrated that the poly-epitope had 57 potential sites for phosphorylation. Furthermore, the secondary of GLSL structure includes 59.42%, 20.94% and 19.63% for random coil, extended strand and alpha-helix, respectively. The GLSL is an immunogenic protein with an acceptable antigenicity (0.8410) and non-allergen. Afterward, 20 potential epitopes of LACK, LEIF, GP63 and SMT antigens were linked by a flexible linker (SAPGTP), then was synthesized, and sub-cloned in pLEXY– neo2. The results were confirmed the expression of 38.7 kDa poly-epitope in secretory and cytosolic sites, separately. Conclusion: A good expression in the L. tarentulae and confirmation of the GLSL poly-epitope could be a basis for developing a vaccine candidate against leishmaniasis that should be confirmed via experimental tests in BALB/c mice.

[1]  A. Daryani,et al.  In silico analysis and expression of a novel chimeric antigen as a vaccine candidate against Toxoplasma gondii. , 2019, Microbial pathogenesis.

[2]  F. Ghaffarifar,et al.  Bioinformatics analysis of ROP8 protein to improve vaccine design against Toxoplasma gondii. , 2018, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[3]  A. Mishra,et al.  Excavating chikungunya genome to design B and T cell multi-epitope subunit vaccine using comprehensive immunoinformatics approach to control chikungunya infection. , 2018, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[4]  A. Majeed,et al.  Current progress of immunoinformatics approach harnessed for cellular- and antibody-dependent vaccine design , 2018, Pathogens and global health.

[5]  M. Bandehpour,et al.  Designing a DNA Vaccine-based Leishmania major Polytope (Preliminary Report) , 2017, Iranian journal of parasitology.

[6]  Shanshan Mao,et al.  Evaluation of tandem Chlamydia trachomatis MOMP multi-epitopes vaccine in BALB/c mice model. , 2017, Vaccine.

[7]  R. Rahbarghazi,et al.  Angiogenic activity of endothelial progenitor cells through angiopoietin-1 and angiopoietin-2 , 2016 .

[8]  Huai-yu Zhou,et al.  Bioinformatics analysis and expression of a novel protein ROP48 in Toxoplasma gondii , 2016, Acta Parasitologica.

[9]  M. Sadeghizadeh,et al.  In silico analysis of an envelope domain III-based multivalent fusion protein as a potential dengue vaccine candidate , 2016, Clinical and experimental vaccine research.

[10]  Navid Nezafat,et al.  A novel multi-epitope peptide vaccine against cancer: an in silico approach. , 2014, Journal of theoretical biology.

[11]  S. Sundar,et al.  Identifying vaccine targets for anti-leishmanial vaccine development , 2014, Expert review of vaccines.

[12]  L. Guizani-Tabbane,et al.  Comparative analysis of resistant and susceptible macrophage gene expression response to Leishmania major parasite , 2013, BMC Genomics.

[13]  M. Topuzogullari,et al.  Conjugation, characterization and toxicity of lipophosphoglycan-polyacrylic acid conjugate for vaccination against leishmaniasis , 2013, Journal of Biomedical Science.

[14]  Z. Hassan,et al.  Enhancement of immune response induced by DNA vaccine cocktail expressing complete LACK and TSA genes against Leishmania major , 2013, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[15]  Yang Zhang,et al.  Improving the physical realism and structural accuracy of protein models by a two-step atomic-level energy minimization. , 2011, Biophysical journal.

[16]  Alfredo Pulvirenti,et al.  Tools and collaborative environments for bioinformatics research , 2011, Briefings Bioinform..

[17]  I. Sharifi,et al.  In Silico Analysis of Six Known Leishmania major Antigens and In Vitro Evaluation of Specific Epitopes Eliciting HLA-A2 Restricted CD8 T Cell Response , 2011, PLoS neglected tropical diseases.

[18]  Pierre Baldi,et al.  High-throughput prediction of protein antigenicity using protein microarray data , 2010, Bioinform..

[19]  Pierre Baldi,et al.  SOLpro: accurate sequence-based prediction of protein solubility , 2009, Bioinform..

[20]  Torsten Schwede,et al.  Automated comparative protein structure modeling with SWISS‐MODEL and Swiss‐PdbViewer: A historical perspective , 2009, Electrophoresis.

[21]  Y. Goto,et al.  Leishmania infantum sterol 24-c-methyltransferase formulated with MPL-SE induces cross-protection against L. major infection. , 2009, Vaccine.

[22]  Y. Goto,et al.  Protective immunization against visceral leishmaniasis using Leishmania sterol 24-c-methyltransferase formulated in adjuvant. , 2007, Vaccine.

[23]  Irini A. Doytchinova,et al.  BMC Bioinformatics BioMed Central Methodology article VaxiJen: a server for prediction of protective antigens, tumour , 2007 .

[24]  P. Y. Chou,et al.  Prediction of the secondary structure of proteins from their amino acid sequence. , 2006 .

[25]  N. Tanner,et al.  Leishmania infantum LeIF protein is an ATP‐dependent RNA helicase and an eIF4A‐like factor that inhibits translation in yeast , 2006, The FEBS journal.

[26]  Sudipto Saha,et al.  Prediction of continuous B‐cell epitopes in an antigen using recurrent neural network , 2006, Proteins.

[27]  Gajendra P. S. Raghava,et al.  AlgPred: prediction of allergenic proteins and mapping of IgE epitopes , 2006, Nucleic Acids Res..

[28]  Morten Nielsen,et al.  Improved method for predicting linear B-cell epitopes , 2006, Immunome research.

[29]  Peter Clote,et al.  DiANNA: a web server for disulfide connectivity prediction , 2005, Nucleic Acids Res..

[30]  Gajendra P. S. Raghava,et al.  BcePred: Prediction of Continuous B-Cell Epitopes in Antigenic Sequences Using Physico-chemical Properties , 2004, ICARIS.

[31]  R. Coler,et al.  Protective efficacy of a tandemly linked, multi-subunit recombinant leishmanial vaccine (Leish-111f) formulated in MPL adjuvant. , 2002, Vaccine.

[32]  Y. Belkaid,et al.  The Potency and Durability of DNA- and Protein-Based Vaccines Against Leishmania major Evaluated Using Low-Dose, Intradermal Challenge , 2001, The Journal of Immunology.

[33]  S. Flohe,et al.  Antigen‐pulsed epidermal Langerhans cells protect susceptible mice from infection with the intracellular parasite Leishmania major , 1998, European journal of immunology.

[34]  P. Tongaonkar,et al.  A semi‐empirical method for prediction of antigenic determinants on protein antigens , 1990, FEBS letters.

[35]  R. Hodges,et al.  New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites. , 1986, Biochemistry.

[36]  E. Emini,et al.  Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide , 1985, Journal of virology.

[37]  P. Karplus,et al.  Prediction of chain flexibility in proteins , 1985, Naturwissenschaften.

[38]  R D Appel,et al.  Protein identification and analysis tools in the ExPASy server. , 1999, Methods in molecular biology.

[39]  J. Gibrat,et al.  GOR method for predicting protein secondary structure from amino acid sequence. , 1996, Methods in enzymology.